XLV: Market Overreaction Could Drive Double Digit Shareholder Yield

Healthcare sector trades at a historic discount due to patent expirations, managed care uncertainty, and drug pricing proposals, but pessimism is overdone. Key catalysts include potential M&A activity and likely continued NIH funding, both of which could drive sector recovery and rerating. XLV stands out among healthcare ETFs for its liquidity, high concentration in undervalued leaders, low turnover, and minimal fees.